Comparison Overview

LLX Solutions LLC

VS

Zydus Group

LLX Solutions LLC

1400 Main St, Waltham, Massachusetts, 02451, US
Last Update: 2025-03-05 (UTC)
Between 800 and 900

Strong

LLX Solutions, a biopharmaceutical services company, provides clinical trial design and Protocol development, statistical analysis, programming, data management and Consulting services to the pharmaceutical, biotechnology, and medical device industries. Its team has proven expertise in supporting global clinical trials for different sizes of companies in the United States in various therapeutic categories such as cardiology, oncology, rare disease, medical devices, pain, infectious diseases, neurology, allergy/immunology, endocrinology/metabolism, gastroenterology and pediatrics. LLX Solutionsโ€™ core competencies are its employees. The key members have over 12 years experience in the industry and have built excellent reputations in the companies they severed. They have been working and providing consultant services for various biotech and pharmaceutical companies such as Wyeth/Pfizer, Shire, Genzyme, Altus, Ariad, Synta, Boston Scientific, etc. With this background, LLX Solutions is committed to provide our clients with the highest quality and timely deliverables. We are dedicated to ensuring that our clients will get the best services from us. The company was founded in 2011 and is headquartered in Waltham, Massachusetts.

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 83
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Zydus Group

Zydus Corporate Park, Nr. Nirma University, Vasihnodevi circle, Mouje - Khoraj, Sarkhej - Gandhinagar Highway, Ahmedabad, Gujarat, IN, 382481
Last Update: 2025-09-07 (UTC)

Strong

Between 800 and 900

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worldwide and is driven by its mission to unlock new possibilities in life-sciences through quality healthcare solutions that impact lives. The group aspires to transform lives through pathbreaking discoveries.

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 19,586
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/llx-solutions-llc.jpeg
LLX Solutions LLC
โ€”
ISO 27001
Not verified
โ€”
SOC 2
Not verified
โ€”
GDPR
No public badge
โ€”
PCI DSS
No public badge
https://images.rankiteo.com/companyimages/zydusuniverse.jpeg
Zydus Group
โ€”
ISO 27001
Not verified
โ€”
SOC 2
Not verified
โ€”
GDPR
No public badge
โ€”
PCI DSS
No public badge
Compliance Summary
LLX Solutions LLC
100%
Compliance Rate
0/4 Standards Verified
Zydus Group
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for LLX Solutions LLC in 2025.

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Zydus Group in 2025.

Incident History โ€” LLX Solutions LLC (X = Date, Y = Severity)

LLX Solutions LLC cyber incidents detection timeline including parent company and subsidiaries

Incident History โ€” Zydus Group (X = Date, Y = Severity)

Zydus Group cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/llx-solutions-llc.jpeg
LLX Solutions LLC
Incidents

No Incident

https://images.rankiteo.com/companyimages/zydusuniverse.jpeg
Zydus Group
Incidents

No Incident

FAQ

Both LLX Solutions LLC company and Zydus Group company demonstrate a comparable AI risk posture, with strong governance and monitoring frameworks in place.

Historically, Zydus Group company has disclosed a higher number of cyber incidents compared to LLX Solutions LLC company.

In the current year, Zydus Group company and LLX Solutions LLC company have not reported any cyber incidents.

Neither Zydus Group company nor LLX Solutions LLC company has reported experiencing a ransomware attack publicly.

Neither Zydus Group company nor LLX Solutions LLC company has reported experiencing a data breach publicly.

Neither Zydus Group company nor LLX Solutions LLC company has reported experiencing targeted cyberattacks publicly.

Neither LLX Solutions LLC company nor Zydus Group company has reported experiencing or disclosing vulnerabilities publicly.

Neither LLX Solutions LLC company nor Zydus Group company has publicly disclosed detailed information about the number of their subsidiaries.

Zydus Group company employs more people globally than LLX Solutions LLC company, reflecting its scale as a Pharmaceutical Manufacturing.

Latest Global CVEs (Not Company-Specific)

Description

pwn.college DOJO is an education platform for learning cybersecurity. In versions up to and including commit 781d91157cfc234a434d0bab45cbcf97894c642e, the /workspace endpoint contains an improper authentication vulnerability that allows an attacker to access any active Windows VM without proper authorization. The vulnerability occurs in the view_desktop function where the user is retrieved via a URL parameter without verifying that the requester has administrative privileges. An attacker can supply any user ID and arbitrary password in the request parameters to impersonate another user. When requesting a Windows desktop service, the function does not validate the supplied password before generating access credentials, allowing the attacker to obtain an iframe source URL that grants full access to the target user's Windows VM. This impacts all users with active Windows VMs, as an attacker can access and modify data on the Windows machine and in the home directory of the associated Linux machine via the Z: drive. This issue has been patched in commit 467db0b9ea0d9a929dc89b41f6eb59f7cfc68bef. No known workarounds exist.

Risk Information
cvss4
Base: 9.5
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:H/VI:H/VA:L/SC:H/SI:H/SA:L/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Adobe Experience Manager versions 11.6 and earlier are affected by a stored Cross-Site Scripting (XSS) vulnerability that could be abused by a low privileged attacker to inject malicious scripts into vulnerable form fields. Malicious JavaScript may be executed in a victimโ€™s browser when they browse to the page containing the vulnerable field. Exploitation of this issue requires user interaction in that a victim must open a malicious link. Scope is changed.

Risk Information
cvss3
Base: 5.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
Description

Adobe Experience Manager versions 11.6 and earlier are affected by a stored Cross-Site Scripting (XSS) vulnerability that could be abused by a low privileged attacker to inject malicious scripts into vulnerable form fields. Malicious JavaScript may be executed in a victimโ€™s browser when they browse to the page containing the vulnerable field. Exploitation of this issue requires user interaction in that a victim must open a malicious link. Scope is changed.

Risk Information
cvss3
Base: 5.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
Description

Adobe Experience Manager versions 11.6 and earlier are affected by a stored Cross-Site Scripting (XSS) vulnerability that could be abused by a low privileged attacker to inject malicious scripts into vulnerable form fields. Malicious JavaScript may be executed in a victimโ€™s browser when they browse to the page containing the vulnerable field. Exploitation of this issue requires user interaction in that a victim must open a malicious link. Scope is changed.

Risk Information
cvss3
Base: 5.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
Description

Adobe Connect versions 12.9 and earlier are affected by a URL Redirection to Untrusted Site ('Open Redirect') vulnerability. An attacker could leverage this vulnerability to redirect users to malicious websites. Exploitation of this issue requires user interaction in that a victim must click on a crafted link.

Risk Information
cvss3
Base: 3.1
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:R/S:U/C:N/I:L/A:N